Study Summary
This trial is testing whether cryoablation, which involves freezing and destroying abnormal tissue, can be an effective treatment for early stage breast cancer in select patients who would otherwise undergo surgery.
- Breast Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: 5 Years
Trial Safety
Safety Progress
Trial Design
0 Treatment Group
200 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Female Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any open slots in this experiment for participants?
"The data found on clinicaltrials.gov suggests that this medical trial is presently recruiting individuals for the study, which was first listed in November 2013 and last updated in April 2018." - Anonymous Online Contributor
How many individuals have been accepted for participation in this experiment?
"Sanarus Technologies, Inc., will be conducting the trial at Epic Care in Emeryville, California and Naples Community Hospital in Naples, Florida. 200 eligible individuals must participate to ensure successful execution of this clinical study." - Anonymous Online Contributor
How many venues are presently conducting this experiment?
"The trial is actively running at 12 sites throughout the United States, including Emeryville, Naples and Lubbock. It's recommended to select your nearest site in order to decrease travel needs if you choose to partake." - Anonymous Online Contributor